Last reviewed · How we verify

NCT05785858

FLUME Catheter Comfort Study

Status unknown Last updated 13 September 2023
What this trial tests

trial in Urinary Catheters in 41 participants. Status unknown.

Timeline
1 June 2023
Primary endpoint
30 March 2024
30 March 2024

Quick facts

Lead sponsorThe Flume Catheter Company Ltd
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment41
Start date1 June 2023
Primary completion30 March 2024
Estimated completion30 March 2024
Sites1 location across United States

Conditions studied

Sponsor

The Flume Catheter Company Ltd

Who can join

18 and older, any sex, with Urinary Catheters or Bladder Pain and Discomfort. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Flume catheter is a commercially available (FDA 510(k) cleared) urethral catheter with an innovative catheter design. The traditional Foley catheter design includes a protruding tip with drainage holes. The protruding tip may contribute to patient discomfort, pain and bladder spasms. The Flume catheter is designed such that the balloon envelops the tip on inflation, thus eliminating the protruding catheter tip, while the drainage holes are inset low in the balloon, providing protection to the bladder lining. Based on the change in design, the hypothesis of this observational cohort study is the Flume catheter will have better patient comfort scores (using validated patient reported outcomes measures) when compared to a traditional catheter.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05785858.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing